AMRX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

AMRXAmneal Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMRX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 3 '26thin chain±22.7%▼−1.13%×0.05

Q2 FY26±15.6%▼−3.14%×0.20

May 8 '26±10.1%▼−3.79%×0.38

Q1 FY26±21.3%▼−1.54%×0.07

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedAMRX realized, solidLLY realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

AMRXAmneal Pharmaceuticals, Inc.

20.13▲+3.52%· post 20.40

Mkt cap$6.4BRevenue$796MQ2 FY26Revenue$3.0BFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

AMRXAmneal Pharmaceuticals, Inc.

LLYELI Lilly & Co

20.13▲+3.52%post 20.40

Price

1,360.90▼−0.28%post 1,358.90

$6.4B

Mkt cap

$1.2T

Q2 FY26$796M

Revenue

$24.4BQ3 FY26

FY25$3.0B

Revenue

$65.2BFY25

AMRX20.13▲+3.52%vsLLY1,360.90▼−0.28%ClosedNov 6 '26